Saturday, March 15, 2025

Creating liberating content

Oracle Corp’s (NYSE: ORCL)...

Oracle Corp (NYSE: ORCL) falls down to its knees, share dropped over 12.15%...

RTX Corp (NYSE: RTX)...

RTX Corp (NYSE: RTX) experienced a notable decline of -7.22%, amounting to $6.03...

GameStop Corp. (NYSE:GME) Quarter...

GameStop Corp. (NYSE: GME) to announce its second quarter fiscal 2023 results after...

Advanced Micro Devices (NASDAQ:AMD)...

Shares of Advanced Micro Devices (NASDAQ:AMD) drops 0.38% in afterhours in last trading...
HomeTagsNASDAQ:SPRO

Tag: NASDAQ:SPRO

GlaxoSmithKline plc (NYSE:GSK) Cheers on...

GlaxoSmithKline plc (NYSE:GSK) shares jumped over 2.11%...

GlaxoSmithKline plc (NYSE:GSK) Cheers on Exclusive Licensing Deal and Selection of First Female CFO

GlaxoSmithKline plc (NYSE:GSK) shares jumped over 2.11% in pre trading session on Monday as it recently announced an exclusive licensing deal with Spero Therapeutics, Inc. (NASDAQ:SPRO) for tebipenem HBr, Spero's late-stage antibiotic asset. Tebipenem HBr is being developed as the first oral carbapenem antibiotic for the treatment of complex urinary tract infections (cUTI) caused by specific bacteria, including pyelonephritis. Chief Commercial Officer of GSK, Luke Miels said, “A new oral antibiotic as an alternative to intravenous hospital treatment for drug-resistant complex urinary tract infections has a significant unmet medical need....

GlaxoSmithKline plc (NYSE:GSK)...

GlaxoSmithKline plc (NYSE:GSK) shares jumped over 2.11% in pre trading session on Monday as it recently announced an exclusive licensing deal with Spero Therapeutics,...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!